Ultrasound contrast agents: basic principles
- PMID: 9652516
- DOI: 10.1016/s0720-048x(98)00057-6
Ultrasound contrast agents: basic principles
Abstract
Introduction: Ultrasonography lacked substances to be administered to patients to improve or increase the diagnostic yield, which is peculiar considering that contrast agents have long been used with all the other imaging techniques. Fortunately some contrast agents, most of them consisting in gas microbubbles, have been recently introduced for ultrasound imaging too: this review will focus on their history, behavior, current applications and future developments. Echocontrast agent research is in progress and many new agents are expected to be marketed this and next year, to be added to Levovist by Schering AG (Berlin, Germany), to enhance the ultrasound signal safely and effectively. No definitive conclusions can be drawn yet on the actual merits of each contrast agent, but all of them seem to be both effective and safe, meaning that their future success will depend on the relative cost-effectiveness and peculiarities.
The basic principles of echocontrast agents: The microbubbles act as echo-enhancers by basically the same mechanism as that determining echo-scattering in all the other cases of diagnostic ultrasound, namely that the backscattering echo intensity is proportional to the change in acoustic impedance between the blood and the gas making the bubbles. The different acoustic impedance at this interface is very high and in fact all of the incident sound is reflected, even though not all of it will of course go back to the transducer. But the acoustic wave reflection, though nearly complete, would not be sufficient to determine a strong US enhancement because the microbubbles are very small and are sparse in the circulation. Moreover, reflectivity is proportional to the fourth power of a particle diameter but also directly proportional to the concentration of the particles themselves.
Second harmonic imaging: As we said above, the microbubbles reached by an ultrasound signal resonate with a specific frequency depending on microbubble diameter. However, the main resonance frequency is not the only resonance frequency of the bubble itself and multiple frequencies of the fundamental one are emitted, just like in a musical instrument. These harmonic frequencies have decreasing intensity, but the second frequency, known as the second harmonic, is still strong enough to be used for diagnostic purposes. The theoretical advantage of the harmonic over the fundamental frequency is that only contrast agent microbubbles resonate with harmonic frequencies, while adjacent tissues do not resonate, or else their harmonic resonation is very little. Thus, using a unit especially set to produce ultrasounds at a given frequency (3.5 MHz) and receive an ultrasound signal twice as powerful (7 MHz) it will be possible to show the contrast agent only, without any artifact from the surrounding anatomical structures, with a markedly improved signal-to-noise ratio. A similar effect to digital subtraction in angiography can thus be obtained, even though through a totally different process. Moreover, second harmonic imaging permits to show extremely small vessels (down to 40 microm) with very slow flow, which would be missed with a conventional method. B-mode imaging can also depict the microbubbles in the myocardium suppressing nearly all the artifacts from cardiac muscle motion. Recently a peculiar behavior of microbubbles has been observed which may permit contrast agent detection even in capillaries. This method is variously known as sonoscintigraphy, loss of correlation, stimulated acoustic emission and transient scattering. The contrast agent microbubbles reached by an ultrasound beam powerful enough explode producing a strong and very short backscatter echo which is read by the unit as a Doppler signal and results in a color pixel where the individual microbubble exploded.
Conclusions: The microbubble contrast agents developed and introduced as safe and effective echo-enhancers in present-day clinical practice will open up new oppurtunities
Similar articles
-
Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.Ital Heart J. 2004 Apr;5(4):309-34. Ital Heart J. 2004. PMID: 15185894 Review.
-
Numerical modeling of microbubble backscatter to optimize ultrasound particle image velocimetry imaging: initial studies.Ultrasonics. 2004 Aug;42(10):1111-21. doi: 10.1016/j.ultras.2004.02.021. Ultrasonics. 2004. PMID: 15234173
-
WE-C-218-01: Ultrasound Contrast Agents.Med Phys. 2012 Jun;39(6Part27):3953. doi: 10.1118/1.4736133. Med Phys. 2012. PMID: 28520019
-
[Contrast media in ultrasonography].Ugeskr Laeger. 1999 May 17;161(20):2938-43. Ugeskr Laeger. 1999. PMID: 10354779 Review. Danish.
-
Overview of echo-enhanced vascular ultrasound imaging for clinical diagnosis in neurosonology.J Neuroimaging. 1997 Apr;7 Suppl 1:S2-14. J Neuroimaging. 1997. PMID: 9128460 Review.
Cited by
-
Ultrasound-stimulated microbubble radiation enhancement of tumors: Single-dose and fractionated treatment evaluation.PLoS One. 2020 Sep 25;15(9):e0239456. doi: 10.1371/journal.pone.0239456. eCollection 2020. PLoS One. 2020. PMID: 32976517 Free PMC article.
-
Contrast efficacy of novel phase convertible nanodroplets for safe CEUS imaging.Sci Rep. 2024 Jul 12;14(1):16126. doi: 10.1038/s41598-024-66163-1. Sci Rep. 2024. PMID: 38997313 Free PMC article.
-
In vivo biological fate of poly(vinylalcohol) microbubbles in mice.Heliyon. 2018 Sep 17;4(9):e00770. doi: 10.1016/j.heliyon.2018.e00770. eCollection 2018 Sep. Heliyon. 2018. PMID: 30238062 Free PMC article.
-
Is bacteriostatic saline superior to normal saline as an echocardiographic contrast agent?Int J Cardiovasc Imaging. 2014 Dec;30(8):1483-9. doi: 10.1007/s10554-014-0493-x. Epub 2014 Jul 15. Int J Cardiovasc Imaging. 2014. PMID: 25017710 Clinical Trial.
-
Diagnostic Value of Contrast-Enhanced Ultrasonography With SonoVue in the Differentiation of Benign and Malignant Breast Lesions: A Meta-Analysis.Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820971583. doi: 10.1177/1533033820971583. Technol Cancer Res Treat. 2020. PMID: 33308040 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
